AbbVie’s $8.7 billion deal for Cerevel has led to a significant payout for Pfizer.
Pfizer created Cerevel with Bain Capital in 2018, spinning out several …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.